Introduction
Due to its involvement in a variety of pathologies (obesity, diabetes, gut inflammation and depression), the melanin concentrating hormone receptor 1 (MCHR1) is a new target for the treatment of these lifestyle diseases. We previously presented the radiosynthesis of [
11C]SNAP-7941, the first potential PET tracer for the MCHR1.
Methods
We herein present its in vitro and in vivo evaluation, including binding affinity, plasma stability, stability against liver mircrosomes and carboxylesterase, lipohilicity, biodistribution, in vivo metabolism and small-animal PET.
Results
[11C]SNAP-7941 evinced high stability against liver microsomes, carboxylesterase and in human plasma. The first small-animal PET experiments revealed a 5 fold increased brain uptake after Pgp/BCRP inhibition. Therefore, it can be assumed that [11C]SNAP-7941 is a Pgp/BCRP substrate. No metabolites were found in brain.
Conclusion
On the basis of these experiments with healthy rats, the suitability of [11C]SNAP-7941 for the visualisation of central and peripheral MCHR1 remains speculative.
